NKT cells: Facts, functions and fallacies

Immunology Today

Volumn 21, Issue 11, 2000, Pages 573-583

  Godfrey, Dale I ^a   Hammond, Kirsten J L ^a   Poulton, Lynn D ^b   Smyth, Mark J ^c   Baxter, Alan G ^b  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE REARRANGEMENT; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCLERODERMA; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; GALACTOSYLCERAMIDES; HUMANS; INFECTION; KILLER CELLS, NATURAL; LIGANDS; MICE; NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 0033662145     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01735-7     Document Type: Review

References (120)

1. + T cells
2. Mouse CD1-specific NK1 T cells - Development, specificity, and function
3. + cells - New clues to their origin, specificity, and function
4. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
5. NKT cells are phenotypically and functionally diverse
6. + T cells in the bone marrow: Divergence from the thymus
7. - NKT cells with distinct TCRalphabeta repertoires and differential distribution in lymphoid tissues
8. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
9. + T cells
10. + T cells
11. + T cells
12. + T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation
13. + T cells lose NK1.1 expression upon in vitro activation
14. - T cell deficiency and IDDM in NOD/Lt mice
15. + cells
16. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
17. - T cells
18. - T cells
19. Close phenotypic and functional similarities between human and murine αβ T Cells expressing invariant TCR α-chains
20. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells
21. CD1-mediated immune responses to glycolipids
22. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
23. + thymocytes selected by MHC class I molecules
24. + cells
25. + T cells
26. + natural killer-T cell development
27. + NKT cells in the early stages of embryogenesis
28. + T cells in vitro from fetal liver precursors
29. + T cells upon antigen expression in the thymus or in the liver
30. + T cells
31. + T lymphocytes: Thymic selection by self antigen
32. + cells in transgenic mice bearing TCR specific for chicken ovalbumin and restricted to I-A(d)
33. + T cells selected by specific class I MHC antigen
34. + T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production
35. + T cell receptor-αβ cell development
36. + thymocytes associated with intact thymic structure
37. Requirement for membrane lymphotoxin in natural killer cell development
38. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells
39. + TCR αβ cell development
40. Induction of differentiation of pre-NKT cells to mature V α 14 NKT cells by granulocyte macrophage colony-stimulating factor
41. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice
42. The Src family tyrosine kinase Fyn regulates natural killer T cell development
43. Lineage relationships and differentiation of natural killer (NK) T cells - Intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules
44. Rapid death and regeneration of NKT cells in anti-CD3-ε- or IL-12-treated mice - A major role for bone marrow in NKT cell homeostasis
45. + NKT Cells
46. + cells originate from multiple pathways
47. +NKT cells to the liver
48. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
49. Natural ligand of mouse CD1d1 - Cellular glycosylphosphatidylinositol
50. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
51. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls
52. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NK T cell activation and antimalarial responses
53. + NKT lymphocytes
54. Murine CD1d-restricted T cell recognition of cellular lipids
55. CD1d-restricted and TCR-mediated activation of V(α)14 NKT cells by glycosylceramides
56. Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties
57. Gene sequences suggest inactivation of α-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys
58. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal(1,4)-D-G1cNAc alpha(1,3)-galactosyltransferase cDNA
59. - T cells produce IL-4
60. + T cells are a potential source of IL-4 during primary immune response
61. + T, cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
62. + T cells upon NKR-P1 cross-linking
63. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function
64. CD161 (NKR-P1a) costimulation of CD1d-dependent activation of human T cells expressing invariant V-α-24J-α-Q TCR-α chains
65. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells
66. + T cells in IL-12-induced immune responses in vivo
67. + thymocyte population associated with intact fas antigen expression
68. Differential tumor surveillance by natural killer (NK) and NKT cells
69. Immunization With α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
70. α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells
71. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
72. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated V α 14 natural killer T cells
73. + NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system
74. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
75. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
76. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
77. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
78. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000
79. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα 14 NKT cells
80. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
81. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
82. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells
83. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD/Lt) mice by the Influence of interleukin (IL)-4 and/or IL-10
84. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immuneprivileged site
85. Direct thymic involvement in anterior chamber-associated immune deviation - Evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice
86. + T cells reciprocally regulate acute graft versus host disease
87. Selective reduction of T cells bearing invariant V-α-24J-α-Q antigen receptor in patients with systemic sclerosis
88. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis
89. Increased interleukin 4 production by NK T cells in systemic lupus erythematosus
90. - αβ-T cell receptor (TCR)-bearing autoreactive T cells from autoimmune NZB x NZW F1 mice
91. Cutting edge: A role for CD1 in the pathogenesis of lupus in NZB/NZW mice
92. + NKT cells associated with disease development in autoimmune-prone mice
93. The development of autoimmunity in C57BL/6 1pr mice correlates with the disappearance of natural killer type-1 positive cells: Evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms
94. +-like thymocytes in the NOD mouse
95. - thymocytes
96. Overexpression of natural killer T cells protects V-α-14-J-α-281 transgenic nonobese diabetic mice against diabetes
97. Diabetes prone BB rats are severely deficient in natural killer T cells
98. Extreme TH1 bias of invariant V-α-24J-α-Q T cells in type 1 diabetes
99. Molecular recognition of lipid antigens by T cell receptors
100. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
101. + natural killer T cells by Mycobacterium bovis bacillus Calmette-Guerin
102. + TCR αβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
103. - T cells with a skewed variable region repertoire after infection with Listeria monocytogenes
104. - T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-γ production
105. + T lymphocytes
106. + T cells induces monocyte chemoattractant protein-1 in early listeriosis
107. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12
108. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from kupffer cells
109. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
110. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
111. The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
112. - αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice
113. TCR V-α-24 and V-β-11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation
114. Differential expression of NK T cell V α 24J α Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
115. + TCR-αβ (intermediate) liver lymphocytes are downregulated by Listeria monocydtogenes
116. + effector function against intracellular infection
117. + T cells producing IL-4 might be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection
118. + αβ T cells in IL-12 production during Salmonella infection
119. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
120. Tracking the response of natural killer T cells to a glycolipid antigen using Cd1D tetramers